New York Urological Associates, PC — New York, New York

New York Urological Associates, PC is a clinical research site located in New York, New York, United States 10022.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

New York Urological Associates, PC has participated in 2 clinical trials.

Therapeutic areas: Overactive Bladder Syndrome (OABS), Hormone-Refractory Prostate Cancer.

Sponsors: Sumitomo Pharma America, Inc., Merrion Pharmaceuticals, LLC.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Urological Associates, PC?

New York Urological Associates, PC has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Urological Associates, PC conducted?

New York Urological Associates, PC has 2 clinical trials on record. Their work covers Overactive Bladder Syndrome (OABS), Hormone-Refractory Prostate Cancer.

Is New York Urological Associates, PC accredited by Crixeo Health?

New York Urological Associates, PC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Urological Associates, PC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.